We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 440

What to Expect From FTC during Trump Administration: New Leader Illuminates
  • Baker & Hostetler LLP
  • USA
  • February 16 2017

On Jan. 25, President Trump named Maureen Ohlhausen as the Federal Trade Commission’s acting chairwoman. A recent speech by Ohlhausen, who has served


Health Law Update - February 9, 2017
  • Baker & Hostetler LLP
  • USA
  • February 9 2017

House Speaker Paul Ryan last week set a deadline of the end of March for repealing most of the Affordable Care Act (ACA), as other Republican leaders


Attorney General Sessions' Focus on Fraud Enforcement to Have Immediate Impact on Federal Government Contractors
  • Baker & Hostetler LLP
  • USA
  • February 9 2017

Today, Feb. 9, former U.S. Senator Jeff Sessions was sworn in as the 84th Attorney General of the United States. While today marked only the


A Look at Potential Supreme Court Nominees’ Class Action Decisions
  • Baker & Hostetler LLP
  • USA
  • January 31 2017

Tonight, President Donald Trump is expected to nominate one of three federal appellate judges to the Supreme Court: Judge William Pryor of the


HHS Ordered To Eliminate Medicare Appeals Backlog By 2021
  • Baker & Hostetler LLP
  • USA
  • January 25 2017

On January 4, 2017, the U.S. District Court for the District of Columbia rejected a request by the Secretary of HHS asking the court to reconsider


Health Law Update - January 12, 2017
  • Baker & Hostetler LLP
  • USA
  • January 12 2017

Welcome to this week's edition of the Health Law Update. In this Issue: CMS Finalizes Mandatory Cardiac and Joint Bundles But Their Future is


Biotech Patent Dispute Between Academics That Is Far From Academic
  • Baker & Hostetler LLP
  • USA
  • January 3 2017

On December 6, 2016, the parties to the complex and soon-to-be departed world of patent Interferences orally argued their positions on motions in


Post Grant Review: 112 and Eligibility Issues in Chemical and Life Sciences
  • Baker & Hostetler LLP
  • USA
  • November 28 2016

Post Grant Review (PGR) petitions are on the rise, and nearly half of all petitions to date have challenged patents in Biotechnology and Organic


Nursing Home Arbitration Ban: There’s a Line in the Sand - But the Tide May Still Come In
  • Baker & Hostetler LLP
  • USA
  • November 17 2016

On November 7, 2016 a federal judge in Mississippi granted a request to temporarily enjoin CMS from implementing a federal rule, scheduled to take


Former Tuomey CEO Settles with DOJ for $1 Million
  • Baker & Hostetler LLP
  • USA
  • November 14 2016

The U.S. Department of Justice (DOJ) recently reached a $1 million settlement with Ralph J. Cox III, the former CEO for Tuomey Health System, Inc